Consumer Research
Cheech and Chong Ink Distribution Deal with Breakthru
LOS ANGELES – Cheech and Chong’s Global Holding Company has ...
Opinion: The Timing Has Never Been Better for Industrial Hemp
LOS ANGELES- A few years ago, ‘sustainable’ was a buzzword. ...
Malta Raises Stock Limits for Cannabis Associations
VALLETTA – Maltese regulators have raised the amounts of Cannabis ...
California DCC Grants $1.8M to UC Berkeley and Glass House Brands for Cannabis Yield Study
LONG BEACH – State regulators have awarded $1.8 million to a partnership between the University of California Berkeley and Glass House Brands to study variations in Cannabis crop yields across cultivation methods, a move that ...
MindMed Rebrands as Definium Therapeutics, Targets 2026 Trials for LSD-Based Treatments
NEW YORK – Mind Medicine (MindMed) Inc., a developer of treatments derived from psychedelics for mental health conditions, has changed its name to Definium Therapeutics Inc., a move that underscores its push into late-stage testing ...
Sunderstorm Welcomes Lime to Its Family of Brands
LOS ANGELES – Sunderstorm, the California-based Cannabis company behind the popular Kanha edibles line, revealed its purchase of Lime, an expert in pre-rolled joints that has carved out a steady presence in the state's retail ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Canopy Growth Locks in Debt Overhaul, Gears Up for Expansion
TORONTO – Canopy Growth Corp. detailed a pair of financial maneuvers aimed at shoring up its books and clearing a path for expansion. The deals, which include a new $150 million U.S. term loan and ...
U.S. Hempcrete Market Set for Steady Rise to $10.6B by 2033
LOS ANGELES – The market for hempcrete, a lightweight composite material derived from the woody core of the hemp plant, stands at $7.83 billion this year and could reach $10.6 billion by 2033. That trajectory ...
From $700 Million Unicorn to Fire-Sale Exit: What the Eaze–Vireo Deal Says About California Cannabis
LOS ANGELES- When Eaze first burst onto the scene, it was marketed as the “Uber of Cannabis”—a tech-enabled delivery platform that promised to professionalize and scale legal access across California. At its peak, Eaze ...
Broad Support in Canada for Psilocybin Use in Palliative Care, New Study Reveals
LOS ANGELES — A recent Canadian study, published in the medical journal Palliative Medicine, has revealed significant public support for the use of psilocybin, a psychedelic compound, in treating existential dread among end-of-life patients. Conducted by ...
Maine Considers Legalizing Cannabis Social Clubs Amid Public Health Concerns
LOS ANGELES- Maine legislators are currently deliberating on a significant bill that could pave the way for the establishment of cannabis social clubs and authorize on-site consumption at dispensaries. This initiative, highlighted in a recent ...
PharmAla Launches “MDXXF” Ticker Amid MDMA Research
LOS ANGELES- PharmAla Biotech Holdings Inc., a biotechnology company specializing in the research, development, and manufacturing of novel MDMA derivatives (MDXX class molecules), has announced the introduction of its new OTC ticker symbol, "MDXXF." This ...
FinCEN’s Corporate Transparency Act Has Arrived
NEW YORK- Enacted by Congress in 2021, the Corporate Transparency Act (CTA) went into effect on January 1, 2024 and affects more than 30 million American small businesses1 and many smaller foreign companies doing business ...
Organigram Advances in Cannabis Market with Strategic British American Tobacco Investment
LOS ANGELES- Organigram Holdings Inc., a significant player in the cannabis industry, has successfully closed the first tranche of a substantial investment from British American Tobacco's subsidiary, BT DE Investments Inc. This move marks a ...
Ohio Cannabis Market Faces Challenges Amid Optimism for Adult-Use Expansion
LOS ANGELES- Ohio's medical cannabis market, one of the nation's most strictly regulated, showed signs of plateauing in 2023, with an increase of just 1.2% in annual sales compared to the previous year. This marks ...
New Jersey Moves Forward with Cannabis Consumption Lounge Regulations
LOS ANGELES- The New Jersey Cannabis Regulatory Commission (CRC) is taking significant strides in the realm of cannabis consumption with the unanimous approval of regulations for consumption lounges, a pivotal development in the state's cannabis ...
Revive Therapeutics Announces $3 Million Private Placement for Clinical and Operational Advancements
Revive Therapeutics Ltd. a prominent player in the biopharmaceutical sector, has recently announced its plan to initiate a significant private placement to fuel its ongoing and future projects. This strategic move, aimed at garnering up ...
Indiana Residents Lean Toward Cannabis Legalization, New Poll Indicates
LOS ANGELES- As Indiana's legislators convene for a new session, the topic of cannabis legalization takes a prominent place in the agenda, bolstered by recent findings from the 2023 Hoosier Survey. Conducted by the Bowen ...
Study: Medical Cannabis Associated With Symptom Improvements In Patients With Major Depressive Disorder
ESSEN, Germany- A new study published in The Journal of Pharmacopsychiatry, reveals a link between the use of medical cannabis products and decreased levels of depression. German researchers investigated the use of medical cannabis in ...
Red Light Holland Advances in Psilocybin Microdosing Capsules for Australasian Market
NEW YORK – Red Light Holland Corp., a leader in the production and distribution of functional mushrooms and psilocybin truffles, has announced significant progress in the development and distribution of its natural psilocybin microdosing capsules. ...
Governor Hochul’s Budget Proposes Key Changes in Cannabis Taxation and Enforcement
NEW YORK– In a significant move towards reforming cannabis policy in New York, Governor Kathy Hochul has introduced pivotal elements in her Fiscal Year 2025 budget that could reshape the landscape of the cannabis industry ...
AlphaFold: AI’s Role in the Future of Psychedelic Drug Development
LOS ANGELES- In the realm of pharmaceutical research, a groundbreaking approach is being adopted in the United Kingdom, where researchers are utilizing AlphaFold, an advanced artificial intelligence tool, to develop new psychedelic drugs potentially useful ...
Michigan’s Cannabis Industry: Balancing Growth and Regulation in a Booming Market
LOS ANGELES- Michigan's cannabis market has witnessed a remarkable surge, with adult-use and medical cannabis sales reaching a staggering $3.6 billion in 2023. This growth represents a 30% increase from the previous year, surpassing the ...
Pioneering the Future of Concussion Management: NFL and University of Regina Partner in Groundbreaking CBD Study
LOS ANGELES- In an era where concussion management is a paramount concern in sports, a revolutionary collaboration between the National Football League (NFL) and the University of Regina is making headlines. The partnership, aimed at ...
FDA’s ‘Breakthrough’ Nod to MM120, An LSD-Derivative, for Anxiety Relief
LOS ANGELES- In a significant development within the field of psychedelic therapy, the Food and Drug Administration (FDA) has recognized the LSD-analog substance MM120, also known as lysergide d-tartrate, with a 'breakthrough therapy' designation for ...
Missouri’s Monumental Task: Expunging 103,558 Cannabis Cases Amid Challenges
LOS ANGELES — In a significant undertaking following the legalization of adult-use cannabis in Missouri, county clerks are rigorously working through an extensive backlog of paper records to identify and expunge cannabis-related convictions. The process, ...
New York Gov. Hochul’s Budget Proposes Shift from Potency to Weight-Based Cannabis Tax
NEW YORK— In a significant move to streamline taxation in the burgeoning cannabis industry, New York Governor Kathy Hochul’s proposed budget for fiscal year 2025 outlines a shift from the current potency-based tax to a ...
California’s Fiscal Challenge: Balancing Budget Deficit with Cannabis Tax Revenue Reallocation
LOS ANGELES- In the face of a significant $37.9 billion budget deficit, California Governor Gavin Newsom has proposed a contentious plan to reallocate funds from the state's cannabis tax revenue. This move has ignited debate ...
Unpacking the Impact: CDTFA’s Strain on California’s Cannabis Industry, Recent Developments, and Industry Advocacy
LOS ANGELES–California, a trailblazer in the legalization of recreational cannabis, has faced challenges as the industry seeks to establish itself and cannabis companies in California make great efforts to flourish within the state. The California ...
Oregon Lawmakers Debate Reversing Drug Decriminalization
LOS ANGELES- In a significant shift in drug policy discussions, Oregon lawmakers from both major political parties are considering proposals to reverse aspects of the state's drug decriminalization, a move that has sparked debate and ...
MedMen Enterprises Inc.: A Tale of Decline in the Cannabis Industry
LOS ANGELES- MedMen Enterprises Inc. a player in the cannabis industry, now faces a precarious future as its stock price plummets. Recent developments have seen the company's stock fall to negligible values, with Green Market ...
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Requirements
Clearmind Medicine Inc. a biotech company in the field of psychedelic-derived therapeutics, has successfully regained compliance with Nasdaq's minimum bid price requirement. The company, known for its innovative approach to addressing major health challenges, received ...
North Carolina Appeals Court Rules on Cannabis Odor and Probable Cause in Vehicle Searches
LOS ANGELES- In a pivotal case that underscores the evolving legal landscape of cannabis laws in the United States, the North Carolina Court of Appeals has recently made a significant ruling. The case revolves around ...
Optimi Health Corp Expands Psychedelic Substance Manufacturing Capabilities with Health Canada License Amendment
LOS ANGELES- Optimi Health Corp. a Health Canada licensed entity engaged in psychedelic substance research and formulation, has achieved a significant milestone in its operational growth. The company announced on January 16, 2024, an amendment ...
